VEGF receptor

Introduction

The Vascular Endothelial Growth Factor Receptor (VEGFR) is a type of receptor tyrosine kinase that plays a crucial role in the regulation of angiogenesis, the process by which new blood vessels form from pre-existing vessels. VEGFRs are primarily expressed on endothelial cells, which line the interior surface of blood vessels, and are activated by binding to vascular endothelial growth factor (VEGF) ligands.

Structure

Structure of VEGF receptor

VEGFRs are transmembrane proteins that consist of an extracellular domain, a single transmembrane helix, and an intracellular tyrosine kinase domain. The extracellular domain is responsible for binding to VEGF ligands and is composed of seven immunoglobulin-like domains. The intracellular domain contains the kinase activity necessary for signal transduction.

Types of VEGF Receptors

There are three main types of VEGF receptors:

• VEGFR-1 (Flt-1): This receptor has a high affinity for VEGF-A and is involved in the regulation of angiogenesis and vascular permeability.
• VEGFR-2 (KDR/Flk-1): This is the principal mediator of the mitogenic, angiogenic, and permeability-enhancing effects of VEGF.
• VEGFR-3 (Flt-4): Primarily involved in lymphangiogenesis, the formation of lymphatic vessels.

Function

VEGF receptor signaling pathways

Upon binding of VEGF to its receptor, VEGFR undergoes dimerization and autophosphorylation of specific tyrosine residues in the intracellular domain. This activation triggers a cascade of downstream signaling pathways, including the PI3K/AKT pathway, the MAPK/ERK pathway, and the PLCγ pathway, which collectively promote endothelial cell proliferation, migration, and survival.

Clinical Significance

VEGFRs are critical targets in the treatment of various diseases characterized by abnormal blood vessel growth, such as cancer, age-related macular degeneration, and diabetic retinopathy. Inhibitors of VEGFR, such as sunitinib and sorafenib, are used as therapeutic agents to block angiogenesis in tumors, thereby inhibiting tumor growth and metastasis.

Related Pages

• Angiogenesis
• Receptor tyrosine kinase
• Vascular endothelial growth factor
• Endothelial cell